1,5-anhydroglucitol monitoring in diabetes: A mass balance perspective

Clinical Biochemistry

Volumn 42, Issue 3, 2009, Pages 158-167

  Nerby, Craig L ^a   Stickle, Douglas F ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

1,5 anhydroglucitol; Diabetes

Indexed keywords

1,5 ANHYDROSORBITOL; HEMOGLOBIN A1C;

DIABETES MELLITUS; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; GLUCOSURIA; HUMAN; HYPERGLYCEMIA; PATIENT MONITORING; PRIORITY JOURNAL; REVIEW;

DEOXYGLUCOSE; DIABETES MELLITUS; HUMANS; HYPERGLYCEMIA; OBSERVER VARIATION; REPRODUCIBILITY OF RESULTS;

EID: 58349117421     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2008.08.086     Document Type: Review

References (61)

1. Yamanouchi T., Tachibana Y., Akanuma H., et al. Origin and disposal of 1,5-anhydroglucitol, a major polyol in the human body. Am J Physiol 263 (1992) E268-E273
2. Kametani S., Hashimoto Y., Yamanouchi T., Akanuma Y., and Akanuma H. Reduced renal reabsorption of 1,5-anhydro-d-glucitol in diabetic rats and mice. J Biochem 102 (1987) 1599-1607
3. Akanuma Y., Morita M., Fukuzawa N., Yamanouchi T., and Akanuma H. Urinary excretion of 1,5-anhydro-d-glucitol accompanying glucose excretion in diabetic patients. Diabetologia 31 (1988) 831-835
4. Yamanouchi T., and Akanuma Y. Serum 1,5-anhydroglucitol (1,5 AG): new clinical marker for glycemic control. Diabetes Res Clin Pract 24 Suppl. (1994) S261-S268
5. Kishimoto M., Yamasaki Y., Kubota M., et al. 1,5-Anhydro-d-glucitol evaluates daily glycemic excursions in well-controlled NIDDM. Diabetes Care 18 (1995) 1156-1159
6. Buse J.B., Freeman J.L., Edelman S.V., Jovanovic L., and McGill J.B. Serum 1,5-anhydroglucitol (GlycoMark): a short-term glycemic marker. Diabetes Technol Ther 5 (2003) 355-363
7. Dungan K.M. 1,5-anhydroglucitol (GlycoMark) as a marker of short-term glycemic control and glycemic excursions. Expert Rev Mol Diagn 8 (2008) 9-19
8. Pitkanen E. Occurrence if 1-5-anhydroglucitol in human cerebrospinal fluid. Clin Chim Acta 48 (1973) 159-166
9. Servo C., and Pitkanen E. Variation in polyol levels in cerebrospinal fluid and serum in diabetic patients. Diabetologia 11 (1975) 575-580
10. Akanuma H., Ogawa K., Lee Y., and Akanuma Y. Reduced levels of plasma 1,5-anhydroglucitol in diabetic patients. J Biochem 90 (1981) 157-162
11. Yoshioka S., Saitoh S., Negishi C., et al. Variations of 1-deoxyglucose(1,5-anhydroglucitol) content in plasma from patients with insulin-dependent diabetes mellitus. Clin Chem 29 (1983) 1396-1398
12. Pitkanen E., and Pitkanen O. The elimination of 1,5-anhydroglucitol administered to rats. Experientia 40 (1984) 463-465
13. Yamanouchi T., Minoda S., Yabuuchi M., et al. Plasma 1,5-anhydro-d-glucitol as new clinical marker of glycemic control in NIDDM patients. Diabetes 38 (1989) 723-729
14. Yamanouchi T., Akaoka I., Akanuma Y., Akanuma H., and Miyashita E. Mechanism for acute reduction of 1,5-anhydroglucitol in rats treated with diabetogenic agents. Am J Physiol 258 (1990) E423-E427
15. Stickle D., and Turk J. A kinetic mass balance model for 1,5-anhydroglucitol: applications to monitoring of glycemic control. Am J Physiol 273 (1997) E821-E830
16. Morita M., and Akanuma H. Distribution of 1,5-anhydro-d-glucitol in normal, diabetic, and perfused rat bodies. J Biochem 112 (1992) 385-388
17. Nowatzke W., Sarno M.J., Birch N.C., Stickle D.F., Eden T., and Cole T.G. Evaluation of an assay for serum 1,5-anhydroglucitol (GlycoMark) and determination of reference intervals on the Hitachi 917 analyzer. Clin Chim Acta 350 (2004) 201-209
18. Robertson D.A., Alberti K.G., Dowse G.K., Zimmet P., Tuomilehto J., and Gareeboo H. Is serum anhydroglucitol an alternative to the oral glucose tolerance test for diabetes screening? The Mauritius Noncommunicable Diseases Study Group. Diabet Med 10 (1993) 56-60
19. Frattali A.L., and Wolf B.A. 1,5-anhydroglucitol: a novel serum marker for screening and monitoring diabetes mellitus?. Clin Chem 40 (1994) 1991-1993
20. Watanabe K., Uchino H., Ohmura C., Tanaka Y., Onuma T., and Kawamori R. Different effects of two alpha-glucosidase inhibitors, acarbose and voglibose, on serum 1,5-anhydroglucitol (1,5AG) level. J Diabetes Complications 18 (2004) 183-186
21. Burtis C.A., Ashwood E.R., and Bruns D.E. Tietz textbook of clinical chemistry and molecular diagnostics. 4th ed (2006), Elsevier Saunders, St. Louis, MO
22. Kilpatrick E.S., Keevilt B.G., Richmond K.L., Newland P., and Addison G.M. Plasma 1,5-anhydroglucitol concentrations are influenced by variations in the renal threshold for glucose. Diabet Med 16 (1999) 496-499
23. Pitkanen E., and Pitkanen O.M. Renal tubular reabsorption of 1,5-anhydro-d-glucitol and d-mannose in vivo in the rat. Pflugers Arch 420 (1992) 367-375
24. Yamanouchi T., Shinohara T., Ogata N., Tachibana Y., Akaoka I., and Miyashita H. Common reabsorption system of 1,5-anhydro-d-glucitol, fructose, and mannose in rat renal tubule. Biochim Biophys Acta 1291 (1996) 89-95
25. Tazawa S., Yamato T., Fujikura H., et al. SLC5A9/SGLT4, a new Na+-dependent glucose transporter, is an essential transporter for mannose, 1,5-anhydro-d-glucitol, and fructose. Life Sci 76 (2005) 1039-1050
26. Emoto M., Tabata T., Inoue T., Nishizawa Y., and Morii H. Plasma 1,5-anhydroglucitol concentration in patients with end-stage renal disease with and without diabetes mellitus. Nephron 61 (1992) 181-186
27. Niwa T., Dewald L., Sone J., Miyazaki T., and Kajita M. Quantification of serum 1,5-anhydroglucitol in uremic and diabetic patients by liquid chromatography/mass spectrometry. Clin Chem 40 (1994) 260-264
28. Ichikawa H., Nagake Y., Takahashi M., et al. What is the best index of glycemic control in patients with diabetes mellitus on hemodialysis?. Nippon Jinzo Gakkai Shi 38 (1996) 305-308
29. Pitkanen E. Proteinuria and plasma hexosugars in early-stage glomerulonephritis. Clin Nephrol 45 (1996) 226-229
30. Yamada H., Hishida A., Kato A., and Yoneyama T. 1,5-anhydroglucitol as a marker for the differential diagnosis of acute and chronic renal failure. Nephron 73 (1996) 707-709
31. Phillipov G., Ninan V.T., and Mathew T.H. Plasma 1,5-anhydro-d-glucitol concentration and its relation to other plasma components in renal failure and renal transplant recipients. Clin Chim Acta 247 (1996) 51-58
32. Fujisawa T., Ikegami H., Tsutsui T., et al. Renal tubular function affects glycosuria-related urinary excretion of 1,5-anhydroglucitol. Diabetes Care 22 (1999) 863-864
33. Shimizu H., Shouzu A., Nishikawa M., et al. Serum concentration and renal handling of 1,5-anhydro-d-glucitol in patients with chronic renal failure. Ann Clin Biochem 36 Pt 6 (1999) 749-754
34. McGill J.B., Cole T.G., Nowatzke W., et al. Circulating 1,5-anhydroglucitol levels in adult patients with diabetes reflect longitudinal changes of glycemia: a U.S. trial of the GlycoMark assay. Diabetes Care 27 (2004) 1859-1865
35. Shibayama M., Oba N., Senda Y., Nishibu M., and Hashimoto T. Clinical evaluation of serum 1,5AG levels in patients with liver cirrhosis. Rinsho Byori 45 (1997) 1187-1190
36. Yamagishi S., and Ohta M. Serum 1,5-anhydro-d-glucitol levels in liver cirrhosis. Acta Diabetol 35 (1998) 65-66
37. Umeda F., Yamauchi T., Ishii H., Nakashima N., Hisatomi A., and Nawata H. Serum 1,5-anhydro-d-glucitol and glycemic control in patients with non-insulin-dependent diabetes mellitus. Tohoku J Exp Med 163 (1991) 93-100
38. Yamanouchi T., Moromizato H., Shinohara T., Minoda S., Miyashita H., and Akaoka I. Estimation of plasma glucose fluctuation with a combination test of hemoglobin A1c and 1,5-anhydroglucitol. Metabolism 41 (1992) 862-867
39. Namba N., Watanabe F., Tokuda M., Mino M., and Furuya E. A new method of quantitating serum and urinary levels of 1,5-anhydroglucitol in insulin-dependent diabetes mellitus. Diabetes Res Clin Pract 24 (1994) 55-61
40. Kawanishi K., Ishida T., Kajikawa T., and Tada S. Clinical laboratory tests in diabetes mellitus. Rinsho Byori 42 (1994) 779-785
41. Phillipou G., James S.K., Frith R.G., Farrant R.K., and Phillips P.J. Enzymatic quantification of 1,5-anhydro-d-glucitol: evaluation and clinical application. Clin Chem 40 (1994) 1322-1326
42. Matsuyama T., Katayama Y., and Fujita S. Recent progress in evaluation of glycemic control by glycated protein and 1,5-AG. Rinsho Byori 43 (1995) 445-448
43. Hotta N., Koh N., Sakakibara F., et al. Effect of acarbose on blood glucose profiles and plasma 1,5-anhydro-d-glucitol in type 2 diabetes poorly controlled by sulfonylurea therapy. Biomed Pharmacother 50 (1996) 297-302
44. Yamanouchi T., Ogata N., Tagaya T., et al. Clinical usefulness of serum 1,5-anhydroglucitol in monitoring glycaemic control. Lancet 347 (1996) 1514-1518
45. Sone H., Okuda Y., Yamaoka T., et al. Predicting long-term glycemic control of post-educational type II diabetic patients by evaluating serum 1,5-anhydroglucitol levels. Diabetes Res Clin Pract 34 (1996) 83-88
46. Yamanouchi T., Inoue T., Ogata E., et al. Post-load glucose measurements in oral glucose tolerance tests correlate well with 1,5-anhydroglucitol, an indicator of overall glycaemic state, in subjects with impaired glucose tolerance. Clin Sci (Lond) 101 (2001) 227-233
47. Dworacka M., Winiarska H., Szymanska M., Kuczynski S., Szczawinska K., and Wierusz-Wysocka B. 1,5-anhydro-d-glucitol: a novel marker of glucose excursions. Int J Clin Pract Suppl 129 (2002) 40-44
48. Dworacka M., and Winiarska H. The application of plasma 1,5-anhydro-d-glucitol for monitoring type 2 diabetic patients. Dis Markers 21 (2005) 127-132
49. Dworacka M., Wender-Ozegowska E., Winiarska H., et al. Plasma anhydro-d-glucitol (1,5-AG) as an indicator of hyperglycaemic excursions in pregnant women with diabetes. Diabet Med 23 (2006) 171-175
50. Nguyen T.M., Rodriguez L.M., Mason K.J., and Heptulla R.A. Serum 1,5-anhydroglucitol (Glycomark) levels in children with and without type 1 diabetes mellitus. Pediatr Diabetes 8 (2007) 214-219
51. Moses A.C., Raskin P., and Khutoryansky N. Does serum 1,5-anhydroglucitol establish a relationship between improvements in HbA1c and postprandial glucose excursions? Supportive evidence utilizing the differential effects between biphasic insulin aspart 30 and insulin glargine. Diabet Med 25 (2008) 200-205
52. Stettler C., Stahl M., Alleman S., et al. Association of 1,5-anhydroglucitol and 2-hour postprandial blood glucose in Type 2 diabetic patients. Diabetes Care 30 (2008) 1534-1535
53. Dungan K.M., Buse J.B., Largay J., et al. 1,5-anhydroglucitol and postprandial hyperglycemia as measured by continuous glucose monitoring system in moderately controlled patients with diabetes. Diabetes Care 29 (2006) 1214-1219
54. Sakata T., Fujimoto K., Kurata K., et al. Role of the glucopyranose ring in the elicitation of feeding. Int J Obes 11 Suppl 3 (1987) 27-33
55. Tsutsui K., Sakata T., Oomura Y., Arase K., Fukushima M., and Hinohara Y. Feeding suppression induced by intra-ventricle III infusion of 1,5-anhydroglucitol. Physiol Behav 31 (1983) 493-502
56. Fujimoto K., Sakata T., Terada K., Arase K., Fukushima M., and Simpson A. Structural evaluation of anorectic action induced by 1,5-anhydro-d-glucitol. Proc Soc Exp Biol Med 178 (1985) 515-522
57. Yamanouchi T., Inoue T., Ichiyanagi K., Sakai T., and Ogata N. 1,5-Anhydroglucitol stimulates insulin release in insulinoma cell lines. Biochim Biophys Acta 1623 (2003) 82-87
58. Kato C., Morishita Y., and Fukatsu T. False-positive increase in 1,5-anhydro-d-glucitol due to Kampo (Japanese herbal) medicine. Rinsho Byori 44 (1996) 396-399
59. Kawasaki T., Yamanouchi T., Kashiwabara A., et al. The influence of traditional Chinese herbal drugs on serum 1, 5-anhydroglucitol levels. Diabetes Res Clin Pract 50 (2000) 97-101
60. American Diabetes Association. Standards of medical care in diabetes-2008. Diabetes Care 31 (2008) S12-S54
61. Sacks D.B., Bruns D.E., Goldstein D.E., Maclaren N.K., McDonald J.M., and Parrott M. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem 48 (2002) 436-472